BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

SCIPHERMEDICINE, INC.

via HART HEALTH STRATEGIES

1st Quarter (Jan 1 - Mar 31) · 2022Posted Apr 20, 2022Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: SCIPHERMEDICINE, INC.
Description: Medical diagnostic company through gene expression
Location: Massachusetts · United States of America

Registrant

Firm: HART HEALTH STRATEGIES
Description: Healthcare Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring health care regulations and legislation.
LobbyistsEMILY GRAHAM · MATTHEW DUCKWORTH · JUDITH GORSUCH
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SCIPHERMEDICINE, INC. — Lobbying — Receipts Report